Comparative Bone Regeneration Potential Studies of Collagen, Heparin, and Polydopamine-Coated Multichannelled BCP Granules
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Gun Hee | - |
dc.contributor.author | Makkar, Preeti | - |
dc.contributor.author | Paul, Kallyanshis | - |
dc.contributor.author | Lee, Byong Taek | - |
dc.date.accessioned | 2021-08-11T12:44:06Z | - |
dc.date.available | 2021-08-11T12:44:06Z | - |
dc.date.issued | 2018-01 | - |
dc.identifier.issn | 1058-2916 | - |
dc.identifier.issn | 1538-943X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/6349 | - |
dc.description.abstract | The current study is a comparative assessment of the bone regeneration potentiality of bone substitutes composed of bioactive polymer-coated biphasic calcium phosphate (BCP) granules. The bone substitutes were primarily composed of multichanneled BCP granules, which were coated separately with biochemical polymer coatings, namely collagen, heparin, or polydopamine (PD), using chemical methods. The morphologic features and chemical structure of the granules and surface coatings were characterized by scanning electron microscopy and Fourier transform infrared spectroscopy, respectively. The biological characterizations in terms of cellular interaction with the bone substitutes in vitro (MTT assay and proliferation) and in vivo (bone regeneration efficacy) were performed and compared with uncoated BCP granules. It was found that PD-coated BCP granules were superior to the others with respect to promoting more rapid healing. Therefore, PD multichannel BCP granule system can be used as a promising injectable bone substitute for clinical applications. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | American Society For Artificial Internal Organs | - |
dc.title | Comparative Bone Regeneration Potential Studies of Collagen, Heparin, and Polydopamine-Coated Multichannelled BCP Granules | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1097/MAT.0000000000000582 | - |
dc.identifier.scopusid | 2-s2.0-85017250676 | - |
dc.identifier.wosid | 000428887200021 | - |
dc.identifier.bibliographicCitation | ASAIO Journal, v.64, no.1, pp 115 - 121 | - |
dc.citation.title | ASAIO Journal | - |
dc.citation.volume | 64 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 115 | - |
dc.citation.endPage | 121 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalResearchArea | Transplantation | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.relation.journalWebOfScienceCategory | Transplantation | - |
dc.subject.keywordPlus | BIPHASIC CALCIUM-PHOSPHATE | - |
dc.subject.keywordPlus | MESENCHYMAL STEM-CELLS | - |
dc.subject.keywordPlus | INJECTABLE BONE | - |
dc.subject.keywordPlus | ELECTROSPUN FIBERS | - |
dc.subject.keywordPlus | IMPLANT | - |
dc.subject.keywordPlus | IMMOBILIZATION | - |
dc.subject.keywordPlus | BIOMATERIALS | - |
dc.subject.keywordPlus | SUBSTITUTE | - |
dc.subject.keywordPlus | INTERFACE | - |
dc.subject.keywordPlus | SCAFFOLDS | - |
dc.subject.keywordAuthor | BCP granule | - |
dc.subject.keywordAuthor | collagen | - |
dc.subject.keywordAuthor | heparin | - |
dc.subject.keywordAuthor | polydopamine | - |
dc.subject.keywordAuthor | injectable bone substitute | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.